Last updated on September 2016

A clinical research study to evaluate the added benefit of an investigational drug in people with moderate Alzheimer’s disease who are currently taking stable doses of Donepezil and either Memantine or Namenda XR.


Brief description of study

A clinical research study to evaluate the added benefit of an investigational drug in people with moderate Alzheimer’s disease who are currently taking stable doses of Donepezil and either Memantine or Namenda XR.

Detailed Study Description

SPRI Clinical Trials of Brooklyn, under the sponsorship of Suven Life Sciences, is currently participating in the clinical evaluation of the safety and effectiveness of an investigational drug in persons with moderate dementia due to Alzheimer’s disease.

Clinical Study Identifier: TX145342

Contact Investigators or Research Sites near you

Start Over

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.